SOLOMON HUGHES recommends Sunjeev Sahota’s recent novel set in a trade union election campaign for its fresh approach to what unites and divides workers, but wishes the union backdrop was truer to life
Worth the risk?
A new funding agency for science claims it will be tolerant of failure – but the signs are that it aims only to replicate existing venture capitalism, write ROX MIDDLETON, LIAM SHAW and JOEL HELLEWELL
CUTTING EDGE: Smart Tissue Autonomous Robot (STAR) which can perform laparoscopic surgery on the soft tissue of a pig without human help
Morning Star international editor ROGER McKENZIE says Trump’s ceaseless belligerence is a desperate effort to prevent the emergence of a multilateral world
Don’t dismiss Lebanon as a side theatre of this war, warns SEVIM DAGDELEN — there are signs Israel has expansion in mind, and it has demonstrated its willingness to expel and kill whole populations
The media present Starmer as staying out of Trump’s war — but we’re already deeply involved in a conflict that sees the US and Israel kill civilians on a huge scale, argues IAN SINCLAIR
LINDA PENTZ GUNTER reports on this week’s conference unveiling the findings of the Gaza Tribunal established by Jeremy Corbyn
CHRISTOPHE IMMER of the Morning Star’s German sister paper Junge Welt reports on a Berlin conference on the politics of art and the legacy of Marxist critic Hans Hess
LAST month the Advanced Research and Invention Agency (Aria) announced the appointment of a new CEO, in line with its intention to launch around the end of this year.
Aria is a new funding agency modelled on venture capital funding for high-risk “moonshot” research that will sit alongside, although independent of the umbrella British research funding agency UK Research and Innovation.
The new CEO, Ilan Gur, has a background in venture capital.
Similar stories
Neutrinos are so abundant that 400 trillion pass through your body every second. ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT explain how scientists are seeking to know more about them
A maverick’s self-inflicted snake bites could unlock breakthrough treatments – but they also reveal deeper tensions between noble scientific curiosity and cold corporate callousness, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
Science has always been mixed up with money and power, but as a decorative facade for megayachts, it risks leaving reality behind altogether, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
A small Japanese trial has reported some positive results for stem cell therapy to treat spinal-cord injuries